6-(3,4-dichloroanilino)-1H-pyrimidine-2,4-dione | 6972-74-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 6-(3,4-dichloroanilino)-1H-pyrimidine-2,4-dione
• CAS: 6972-74-3
• 化学式: C₁₀H₇Cl₂N₃O₂
• 分子量: 272.09
• InChiKey: LIRVMDIXHXAYMS-UHFFFAOYSA-N

物化性质

• 密度：
  1.585±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  70.2
• 氢给体数：
  3
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  6-(3,4-dichloroanilino)-1H-pyrimidine-2,4-dione 、 2-氟-3-(三氟甲基)苯甲醛 以 N,N-二甲基甲酰胺 为溶剂， 反应 4.0h， 以62%的产率得到10-(3,4-dichlorophenyl)-9-(trifluoromethyl)-2H,3H,4H, 10H-pyrimido[4,5-b]quinoline-2,4-dione
  参考文献：
  名称：

  5-Deazaflavin derivatives as inhibitors of p53 ubiquitination by HDM2

  摘要：

  Based on previous reports of certain 5-deazaflavin derivatives being capable of activating the tumour suppressor p53 in cancer cells through inhibition of the p53-specific ubiquitin E3 ligase HDM2, we have conducted an structure-activity relationship (SAR) analysis through systematic modification of the 5-deazaflavin template. This analysis shows that HDM2-inhibitory activity depends on a combination of factors. The most active compounds (e. g., 15) contain a trifluoromethyl or chloro substituent at the deazaflavin C9 position and this activity depends to a large extent on the presence of at least one additional halogen or methyl substituent of the phenyl group at N10. Our SAR results, in combination with the HDM2 RING domain receptor recognition model we present, form the basis for the design of drug-like and potent activators of p53 for potential cancer therapy. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2013.09.038
• 作为产物：
  描述：

  6-氯尿嘧啶 、 3,4-二氯苯胺 以 乙二醇甲醚 为溶剂， 生成 6-(3,4-dichloroanilino)-1H-pyrimidine-2,4-dione
  参考文献：
  名称：

  嘧啶，嘌呤和嘌呤核苷类似物的卤代苯胺衍生物：合成和抗人巨细胞病毒的活性。

  摘要：

  在苯胺环上带有3,4-或3,5-二氯取代基的2-苯胺嘌呤和6-苯胺基嘧啶可抑制人巨细胞病毒（HCMV）感染的人胚肺（HEL）细胞培养的病毒特异性DNA合成。通常，活性化合物对病毒与宿主细胞DNA的合成具有中等至低的选择性。2-（3,5-二氯苯胺基）嘌呤的核苷和无环核苷类似物以相似的浓度抑制HCMV和细胞DNA的合成。2-Amino-4-chloro-6-（3,5-dichloroanilino）pyrimidine和几种相关化合物在产量降低试验中以对HEL细胞无毒的浓度抑制了HCMV生长。

  DOI：

  10.1021/jm00010a026

文献信息

• Haloanilino Derivatives of Pyrimidines, Purines, and Purine Nucleoside Analogs: Synthesis and Activity against Human Cytomegalovirus
  作者：Maria Medveczky、Te-Fang Yang、Joseph Gambino、Peter Medveczky、George E. Wright

  DOI：10.1021/jm00010a026

  日期：1995.5

  DNA synthesis by human cytomegalovirus (HCMV)-infected human embryonic lung (HEL) cells in culture. In general, active compounds had moderate to low selectivity for viral vs host cell DNA synthesis. Nucleoside and acyclonucleoside analogs of 2-(3,5-dichloroanilino)purines inhibited both HCMV and cellular DNA synthesis at similar concentrations. 2-Amino-4-chloro-6-(3,5-dichloroanilino)pyrimidine and

  在苯胺环上带有3,4-或3,5-二氯取代基的2-苯胺嘌呤和6-苯胺基嘧啶可抑制人巨细胞病毒（HCMV）感染的人胚肺（HEL）细胞培养的病毒特异性DNA合成。通常，活性化合物对病毒与宿主细胞DNA的合成具有中等至低的选择性。2-（3,5-二氯苯胺基）嘌呤的核苷和无环核苷类似物以相似的浓度抑制HCMV和细胞DNA的合成。2-Amino-4-chloro-6-（3,5-dichloroanilino）pyrimidine和几种相关化合物在产量降低试验中以对HEL细胞无毒的浓度抑制了HCMV生长。
• Inhibitors of Bacillus subtilis DNA polymerase III. 6-Anilinouracils and 6-(alkylamino)uracils
  作者：George E. Wright、Neal C. Brown

  DOI：10.1021/jm00175a007

  日期：1980.1

  irreversibly binding to the enzyme. Several 6-(alkylamino)uracils were weak inhibitors of DNA polymerases III; the optimum alkyl groups for enzyme binding were n-pentyl and n-hexyl, which apparently can occupy the planar enzyme binding site. The varied activities of 6-anilinouracils on a mutant DNA polymerase, resistant to 6-(phenylhydrazino)- and 6-(benzylamino)uracils bearing a p-OH or NH2 group, have altered

  发现取代的6-茴香胺嘧啶是来自枯草芽孢杆菌的复制特异性酶DNA聚合酶III的有效抑制剂。通过在苯环的间位和对位包含小烷基或卤素，可以最大程度地发挥抑制作用。极性取代基大大降低了活性。定性结构-活性关系表明，该元位置可以耐受较大的基团，这表明该位置可能适合引入能够不可逆地结合酶的基团。几种6-（烷基氨基）尿嘧啶是DNA聚合酶III的弱抑制剂。用于酶结合的最佳烷基是正戊基和正己基，它们显然可以占据平面酶结合位点。6-苯胺嘧啶对突变型DNA聚合酶的各种活性，
• 5-Deazaflavin derivatives as inhibitors of p53 ubiquitination by HDM2
  作者：Michael P. Dickens、Patricia Roxburgh、Andreas Hock、Mokdad Mezna、Barrie Kellam、Karen H. Vousden、Peter M. Fischer

  DOI：10.1016/j.bmc.2013.09.038

  日期：2013.11

  Based on previous reports of certain 5-deazaflavin derivatives being capable of activating the tumour suppressor p53 in cancer cells through inhibition of the p53-specific ubiquitin E3 ligase HDM2, we have conducted an structure-activity relationship (SAR) analysis through systematic modification of the 5-deazaflavin template. This analysis shows that HDM2-inhibitory activity depends on a combination of factors. The most active compounds (e. g., 15) contain a trifluoromethyl or chloro substituent at the deazaflavin C9 position and this activity depends to a large extent on the presence of at least one additional halogen or methyl substituent of the phenyl group at N10. Our SAR results, in combination with the HDM2 RING domain receptor recognition model we present, form the basis for the design of drug-like and potent activators of p53 for potential cancer therapy. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.